Inceptive, whose AI-based software designs unique mRNA-based molecules that are licensed out to pharmaceutical companies, raised $100M from Nvidia and a16z (Madhumita Murgia/Financial Times)

Inceptive, whose AI-based software designs unique mRNA-based molecules that are licensed out to pharmaceutical companies, raised $100M from Nvidia and a16z (Madhumita Murgia/Financial Times)

Madhumita Murgia / Financial Times:
Inceptive, whose AI-based software designs unique mRNA-based molecules that are licensed out to pharmaceutical companies, raised $100M from Nvidia and a16z  —  Inceptive’s Jakob Uszkoreit, a pioneer of the technology behind ChatGPT, attracts Nvidia funding to design ‘biological software’